PEGASYS 180 MCG 0.5 ML 1 SIRIN (Peginterferon alpha-2a ) ROCHE
All Europe delivery. Shipping time 7-10 days. Price for shipping individual for each country. Usually 40-50 euro. Payment when sending the goods.
Worldwide shipping possible too.
Chronic hepatitis C
Adult patients
Pegasis® in combination with other medicinal products is indicated for the treatment of chronic hepatitis C (HCV) in patients with compensated liver disease
Children aged 5 and over
In combination with ribavirin for the treatment of chronic hepatitis C in previously untreated children and adolescents aged 5 years and older with a positive serum analysis for hepatitis C virus (HCV) RNA.
Chronic hepatitis B
Adult patients
Treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B (HCV) in adult patients with compensated liver damage and signs of viral replication, elevated alanine aminotransferase (ALT) and histologically confirmed liver inflammation and/or fibrosis
Children aged 3 and over
Treatment of HBeAg-positive CHB in children and adolescents aged 3 years and older who do not have cirrhosis, with signs of viral replication and a persistently elevated level of ALT in blood serum. To make a decision about the start of treatment for children
-
Commercial name:Пегасис
-
Сhemical name:Пегинтерферон альфа-2а
-
Dosage:180
-
Quantity:one
-
Release form:Syringe
-
Виробник:Австрия